Incidence of the Factor V Leiden-mutation, Coagulation Inhibitor Deficiency, and Elevated Antiphospholipid-antibodies in Patients with Preeclampsia or HELLP-Syndrome

By von Tempelhoff G.-F.   Heilmann L.   Spanuth E.   Kunzmann E.   Hommel G.  

Thrombosis Research, Vol. 100, Iss. 4, 2000-11 ,pp. : 363-365

Elsevier

Access to resources Recommend Favorite

Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden

By Flores-Nascimento M. C.   Beltrame M. P.   De Paula E. V.   Montalvao S. L.   Pereira F. G.   Orsi F. L. A.   Lorand-Metze I.   Annichino-Bizzacchi J. M.  

Platelets, Vol. 20, Iss. 6, 2009-09 ,pp. : 367-375

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of Factor V 1691 G–A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients

By Eroglu Aydan   Ulu Arzu   Çam Ragip   Kurtman Cengiz   Akar Nejat  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 1, 2007-02 ,pp. : 31-34

Springer Publishing Company

Access to resources Recommend Favorite

Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis

By van Dunné F.M.  

Human Reproduction, Vol. 20, Iss. 3, 2005-03 ,pp. : 802-806

Oxford University Press

Access to resources Recommend Favorite

Hyperhomocysteinemia and Other Newly Recognized Inherited Coagulation Disorders (Factor V Leiden and Prothrombin Gene Mutation) in Patients with Idiopathic Cerebral Vein Thrombosis

By  

Cerebrovascular Diseases, Vol. 17, Iss. 2-3, 2003-12 ,pp. : 153-159

Karger

Access to resources Recommend Favorite